Skip to content
Bamboo WorksBamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Beijing Ruiye

Sihuan Pharmaceutical announced Tuesday that four non-PVC solid-liquid double chamber bag products developed by its Beijing Ruiye affiliate have been included in the 2023 edition of China’s National Reimbursement Drug List under the nation’s health plan.

FAST NEWS: Four Sihuan affiliate products included in China’s national health plan

The latest: Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) announced Tuesday that four non-PVC solid-liquid double chamber bag products developed by its Beijing Ruiye affiliate have been included in the 2023 edition of…
January 10, 2024
0460.HK

Recent Articles

Sihuan Pharmaceutical announced Tuesday that four non-PVC solid-liquid double chamber bag products developed by its Beijing Ruiye affiliate have been included in the 2023 edition of China’s National Reimbursement Drug List under the nation’s health plan.
January 10, 2024

FAST NEWS: Four Sihuan affiliate products included in China’s national health plan

0460.HK

RECENT ARTICLES

  1. Everest's nefecon included on national drug list
    December 2, 2024
    Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  2. December 5, 2024
    Xuanzhu Biopharm set for spin-off in Hong Kong IPO
    0460.HK
  3. December 3, 2024
    A McDonald’s Valuation Downsize, and New Medical Plan Additions
  4. January 9, 2025
    Cancer drug maker Genfleet joins Hong Kong IPO influx
  5. March 6, 2025
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  6. November 27, 2024
    Lenovo’s AI seeds begin bearing fruit, as geopolitics continue to weigh
    0992.HK LNVGY.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.